bioAffinity Technologies has raised $3.2 million through a public offering. The company sold shares and pre-funded warrants as part of the offering, with reports indicating the sale of 4 million shares and up to 2.96 million pre-funded warrants. The details of the sale, including the exact number of shares and warrants sold, are not entirely clear from the available information.